Abstract:Background: KIAA0101, previously identified as proliferating cell nuclear antigen (PCNA)-associated factor, is overexpressed among almost majority of human cancers and has emerged as an important regulator of tumorigenesis and cancer progression; however, its expression, function and underlying molecular mechanisms in the development of human nasopharyngeal carcinoma (NPC) remain unknown.Methods: Integrated bioinformatics approaches were employed to determine the differentially expressed genes and KIAA0101 expression levels in the NPC samples compared with normal controls by using gene profiling data from GSE6631, GSE12452 and TCGA-HNSC. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the KIAA0101 mRNA expressions in NPC cell lines. PSCSI-GFP lentiviral vectors carrying KIAA0101 short hairpin RNA (shRNA) were constructed and stable transfected cells were then validated by immunofluorescence, qRT-PCR and western blot for further investigating the effect of KIAA0101 on malignant phenotypes of NPC cells. The effect of KIAA0101 on cell proliferation and apoptosis were evaluated by immunofluorescence, MTT, colony formation and flow cytometry. LinkedOmics was also employed to explore the primary biological process and KEGG pathways correlated with KIAA0101. Flow cytometry and Brdu staining were used to investigate the role of KIAA0101 in the process of cell cycle and DNA replication. Mechanistic studies were systematically investigated by UCSC Genome Browser, GEO, UALCAN, transcriptional factors prediction by QIAGEN, PROMO and JASPAR, ChIP, qRT-PCR, and the cBioPortal for Cancer Genomics, et al.Results: The result showed that KIAA0101 ranked top overexpressed gene lists in GSE6631 expression data. KIAA0101 was highly expressed in the NPC or HNSC tissues and NPC cell lines, and higher expression of KIAA0101 was correlated with tumor grade. Furthermore, knockdown of KIAA0101 significantly inhibited NPC cell proliferation and DNA replication, promoted apoptosis and cell cycle arrest in vitro. Meanwhile, the mechanistic study revealed that MAP kinase phosphorylation-dependent activation of the transcription factor ELK1 enhanced neighbor gene expressions of KIAA0101 and TRIP4 by binding both promotor regions in the NPC cells.Conclusions: Taken together, our findings indicate that overexpression of KIAA0101 regulated by MAP kinase phosphorylation-dependent activation of ELK1 plays an important role in NPC development and progression. Targeting KIAA0101 or ELK1 may provide the promising therapeutic potential for NPC treatment.Funding Statement: This work was supported by the Natural Science Foundation of Jiangsu Province (No. BK20150556), Six Talent Peaks Project in Jiangsu Province (No. YY-076), Project funded by China Postdoctoral Science Foundation (No. 2016M603065, No. 2018T111164) and China Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1601159B).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: The study protocol was approved by the Ethics Committee of Medical school of Nanjing University. Data collections and processions were performed according to policies of GEO and TCGA project.

PDZ Binding Kinase (PBK) is a Theranostic Target for Nasopharyngeal Carcinoma: Driving Tumor Growth Via ROS Signaling and Correlating with Patient Survival

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort

Up-regulation of Polo-like Kinase 1 in Nasopharyngeal Carcinoma Tissues: a Comprehensive Investigation Based on RNA-sequencing, Gene Chips, and In-House Tissue Arrays.

PDZ-binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway.

PDZ-binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway

PKCα is a Potentially Useful Marker for Planning Individualized Radiotherapy for Nasopharyngeal Carcinoma

Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma

PNCK Depletion Inhibits Proliferation and Induces Apoptosis of Human Nasopharyngeal Carcinoma Cells in Vitro and in Vivo

Upregulation of PNCK Promotes Metastasis and Angiogenesis Via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma

High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma

Integrated analysis of bulk and single-cell RNA sequencing reveals the interaction of PKP1 and tumor-infiltrating B cells and their therapeutic potential for nasopharyngeal carcinoma

MAPK-ELK1 Signaling Pathway Mediated Overexpression of PCNA-Associated Factor KIAA0101 Controls Cell Proliferation and Apoptosis in Nasopharyngeal Carcinoma: an Integrated Experimental and Bioinformatics Analysis

MicroRNA-372 Enhances Radiosensitivity While Inhibiting Cell Invasion and Metastasis in Nasopharyngeal Carcinoma Through Activating the PBK-dependent P53 Signaling Pathway

Expression patterns and clinical significances of PBK in lung cancer: an analysis based on Oncomine database

An Integrative Pan-Cancer Analysis of PBK in Human Tumors

Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

Increase in Ikappab Kinase Alpha Expression Suppresses the Tumor Progression and Improves the Prognosis for Nasopharyngeal Carcinoma

Polo-Like Kinase 1 Phosphorylates and Stabilizes KLF4 to Promote Tumorigenesis in Nasopharyngeal Carcinoma.